Rupali K. Vohra

Glostrup, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via Improved Glucose Metabolism.

Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via Improved Glucose Metabolism.

Journal: Investigative ophthalmology & visual science

Published: February 10, 2026

Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma.

Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma.

Journal: Molecular brain

Published: February 03, 2025

Correction: Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension.

Correction: Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension.

Journal: Cellular and molecular neurobiology

Published: October 04, 2024

Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension.

Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension.

Journal: Cellular and molecular neurobiology

Published: April 16, 2024

Distinct Metabolic Profiles of Ocular Hypertensives in Response to Hypoxia.

Distinct Metabolic Profiles of Ocular Hypertensives in Response to Hypoxia.

Journal: International journal of molecular sciences

Published: November 26, 2023

Potential Retinal Biomarkers in Alzheimer's Disease.

Potential Retinal Biomarkers in Alzheimer's Disease.

Journal: International journal of molecular sciences

Published: September 01, 2023

Prevention of Cell Death by Activation of Hydroxycarboxylic Acid Receptor 1 (GPR81) in Retinal Explants.

Prevention of Cell Death by Activation of Hydroxycarboxylic Acid Receptor 1 (GPR81) in Retinal Explants.

Journal: Cells

Published: May 13, 2022

Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?

Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?

Journal: Frontiers in neuroscience

Published: November 28, 2021

Oxidative Stress in Optic Neuropathies.

Oxidative Stress in Optic Neuropathies.

Journal: Antioxidants (Basel, Switzerland)

Published: August 18, 2021

Decreased Glucose Metabolism and Glutamine Synthesis in the Retina of a Transgenic Mouse Model of Alzheimer's Disease.

Decreased Glucose Metabolism and Glutamine Synthesis in the Retina of a Transgenic Mouse Model of Alzheimer's Disease.

Journal: Cellular and molecular neurobiology

Published: April 29, 2021

Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction.

Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction.

Journal: Redox biology

Published: February 25, 2021

Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in vitro.

Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in vitro.

Journal: Biomedicine hub

Published: February 22, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026